DOPAMINE MERCAPTURATE CAN AUGMENT DOPAMINERGIC NEURODEGENERATION1 *

By MONTINE THOMAS   AMARNATH VENTKATARAMAN   PICKLO MATTHEW   SIDELL KATHRIN   ZHANG JING   GRAHAM DOYLE  

Drug Metabolism Reviews, Vol. 32, Iss. 3-4, 2000-10 ,pp. : 363-376

Informa Healthcare

Access to resources Recommend Favorite

Pramipexole increases vesicular dopamine uptake: implications for treatment of Parkinson's neurodegeneration

By Truong J.G.   Rau K.S.   Hanson G.R.   Fleckenstein A.E.  

European Journal of Pharmacology, Vol. 474, Iss. 2, 2003-08 ,pp. : 223-226

Elsevier

Access to resources Recommend Favorite

Dopamine D1 Receptors, Regulation of Gene Expression in the Brain, and Neurodegeneration

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 5, 2010-11 ,pp. : 526-538

Bentham Science Publishers

Access to resources Recommend Favorite

From Stem Cells to Dopamine Neurons: Developmental Biology Meets Neurodegeneration

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 7, 2012-11 ,pp. : 893-896

Bentham Science Publishers

Access to resources Recommend Favorite

Dopamine D 2 receptor agonists protect against ischaemia-induced hippocampal neurodegeneration in global cerebral ischaemia

By O'Neill M.J.   Hicks C.A.   Ward M.A.   Cardwell G.P.   Reymann J.-M.   Allain H.   Bentue-Ferrer D.  

European Journal of Pharmacology, Vol. 352, Iss. 1, 1998-07 ,pp. : 37-46

Elsevier

Access to resources Recommend Favorite